Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020
Background: The distribution and nature of symptoms among SARS-CoV-2 infected individuals need to be clarified. Methods: Between May and August 2020, 11 138 healthcare and administrative personnel from Central Denmark Region were tested for SARS-CoV-2 antibodies and subsequently completed a question...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971221005063 |
id |
doaj-ae12efa8bf0d454baf5c09287853d134 |
---|---|
record_format |
Article |
spelling |
doaj-ae12efa8bf0d454baf5c09287853d1342021-08-28T04:41:47ZengElsevierInternational Journal of Infectious Diseases1201-97122021-08-011091723Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020Kathrine Agergård Kaspersen0Thomas Greve1Kent Jacob Nielsen2Sanne Jespersen3Susan Mikkelsen4Jesper Medom Vestergaard5Jacob Dvinge Redder6Martin Tolstrup7Marianne Kragh Thomsen8Holger Jon Møller9Lars Østergaard10Henrik Albert Kolstad11Christian Erikstrup12Department of Clinical Immunology, Aarhus University Hospital, DK-8200 Aarhus N, Denmark; Danish Big Data Centre for Environment and Health (BERTHA), Aarhus University, DK-4000 Roskilde, Denmark; Corresponding author at: Department of Clinical Immunology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.Department of Clinical Microbiology, Aarhus University Hospital, DK-8200 Aarhus N, DenmarkDepartment of Occupational Medicine, Herning Regional Hospital, DK-7400 Herning, DenmarkDepartment of Infectious Diseases, Aarhus University Hospital, DK-8200 Aarhus N, DenmarkDepartment of Clinical Immunology, Aarhus University Hospital, DK-8200 Aarhus N, DenmarkDepartment of Occupational Medicine, Herning Regional Hospital, DK-7400 Herning, Denmark; Department of Occupational Medicine, Aarhus University Hospital, DK-8200 Aarhus N, DenmarkBusiness Intelligence, Central Denmark Region, DK-8200 Aarhus N, DenmarkDepartment of Infectious Diseases, Aarhus University Hospital, DK-8200 Aarhus N, DenmarkDepartment of Clinical Microbiology, Aarhus University Hospital, DK-8200 Aarhus N, DenmarkDepartment of Clinical Biochemistry, Aarhus University Hospital, DK-8200 Aarhus N, DenmarkDepartment of Infectious Diseases, Aarhus University Hospital, DK-8200 Aarhus N, DenmarkDepartment of Occupational Medicine, Aarhus University Hospital, DK-8200 Aarhus N, DenmarkDepartment of Clinical Immunology, Aarhus University Hospital, DK-8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, DK-8000 Aarhus C, DenmarkBackground: The distribution and nature of symptoms among SARS-CoV-2 infected individuals need to be clarified. Methods: Between May and August 2020, 11 138 healthcare and administrative personnel from Central Denmark Region were tested for SARS-CoV-2 antibodies and subsequently completed a questionnaire. Symptom prevalence and overall duration for symptoms persisting for more than 30 days were calculated. Logistic regression models were used to estimate adjusted odds ratios (ORs) with 95% CIs. Results: In total, 447 (4%) of the participants were SARS-CoV-2-seropositive. Loss of sense of smell and taste was reported by 50% of seropositives compared with 3% of seronegatives. Additionally, seropositives more frequently reported fever, dyspnoea, muscle or joint ache, fatigue, cough, headache and sore throat, and they were more likely to report symptoms persisting for more than 30 days. In adjusted models, they had a higher risk of reporting symptoms, with the strongest association observed for loss of sense of taste and smell (OR = 35.6; 95% CI: 28.6–44.3). Conclusion: In this large study, SARS-CoV-2-seropositive participants reported COVID-19-associated symptoms more frequently than those who were seronegative, especially loss of sense of taste and smell. Overall, their symptoms were also more likely to persist for more than 30 days.http://www.sciencedirect.com/science/article/pii/S1201971221005063SARS-CoV-2COVID-19SymptomsPrevalenceLong-term symptomsSerosurvey |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kathrine Agergård Kaspersen Thomas Greve Kent Jacob Nielsen Sanne Jespersen Susan Mikkelsen Jesper Medom Vestergaard Jacob Dvinge Redder Martin Tolstrup Marianne Kragh Thomsen Holger Jon Møller Lars Østergaard Henrik Albert Kolstad Christian Erikstrup |
spellingShingle |
Kathrine Agergård Kaspersen Thomas Greve Kent Jacob Nielsen Sanne Jespersen Susan Mikkelsen Jesper Medom Vestergaard Jacob Dvinge Redder Martin Tolstrup Marianne Kragh Thomsen Holger Jon Møller Lars Østergaard Henrik Albert Kolstad Christian Erikstrup Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020 International Journal of Infectious Diseases SARS-CoV-2 COVID-19 Symptoms Prevalence Long-term symptoms Serosurvey |
author_facet |
Kathrine Agergård Kaspersen Thomas Greve Kent Jacob Nielsen Sanne Jespersen Susan Mikkelsen Jesper Medom Vestergaard Jacob Dvinge Redder Martin Tolstrup Marianne Kragh Thomsen Holger Jon Møller Lars Østergaard Henrik Albert Kolstad Christian Erikstrup |
author_sort |
Kathrine Agergård Kaspersen |
title |
Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020 |
title_short |
Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020 |
title_full |
Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020 |
title_fullStr |
Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020 |
title_full_unstemmed |
Symptoms reported by SARS-CoV-2 seropositive and seronegative healthcare and administrative employees in Denmark from May to August 2020 |
title_sort |
symptoms reported by sars-cov-2 seropositive and seronegative healthcare and administrative employees in denmark from may to august 2020 |
publisher |
Elsevier |
series |
International Journal of Infectious Diseases |
issn |
1201-9712 |
publishDate |
2021-08-01 |
description |
Background: The distribution and nature of symptoms among SARS-CoV-2 infected individuals need to be clarified. Methods: Between May and August 2020, 11 138 healthcare and administrative personnel from Central Denmark Region were tested for SARS-CoV-2 antibodies and subsequently completed a questionnaire. Symptom prevalence and overall duration for symptoms persisting for more than 30 days were calculated. Logistic regression models were used to estimate adjusted odds ratios (ORs) with 95% CIs. Results: In total, 447 (4%) of the participants were SARS-CoV-2-seropositive. Loss of sense of smell and taste was reported by 50% of seropositives compared with 3% of seronegatives. Additionally, seropositives more frequently reported fever, dyspnoea, muscle or joint ache, fatigue, cough, headache and sore throat, and they were more likely to report symptoms persisting for more than 30 days. In adjusted models, they had a higher risk of reporting symptoms, with the strongest association observed for loss of sense of taste and smell (OR = 35.6; 95% CI: 28.6–44.3). Conclusion: In this large study, SARS-CoV-2-seropositive participants reported COVID-19-associated symptoms more frequently than those who were seronegative, especially loss of sense of taste and smell. Overall, their symptoms were also more likely to persist for more than 30 days. |
topic |
SARS-CoV-2 COVID-19 Symptoms Prevalence Long-term symptoms Serosurvey |
url |
http://www.sciencedirect.com/science/article/pii/S1201971221005063 |
work_keys_str_mv |
AT kathrineagergardkaspersen symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT thomasgreve symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT kentjacobnielsen symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT sannejespersen symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT susanmikkelsen symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT jespermedomvestergaard symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT jacobdvingeredder symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT martintolstrup symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT mariannekraghthomsen symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT holgerjonmøller symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT larsøstergaard symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT henrikalbertkolstad symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 AT christianerikstrup symptomsreportedbysarscov2seropositiveandseronegativehealthcareandadministrativeemployeesindenmarkfrommaytoaugust2020 |
_version_ |
1721187881811181568 |